Shares of Westlake Village-based biotech company MannKind were down more than 7 percent in early trading May 7, after it reported sluggish revenue growth and net losses of 8 cents per share. Revenue for the company’s first quarter continued to rise to $17.5 million, up from $3.5 million in the previous first quarter. Of that,…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
